chrisvoncsefalvay/vaers-outcomes huggingface dataset:
raised hot spot of 4 inches below the injection site; fatigued; arm was sore; chills; temperature of 101.2 degrees Fahrenheit; Headache; muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (raised hot spot of 4 inches below the injection site), PAIN IN EXTREMITY (arm was sore), CHILLS (chills), PYREXIA (temperature of 101.2 degrees Fahrenheit) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018821A and 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.  Concomitant products included FLUTICASONE PROPIONATE (FLOVENT), LEVOSALBUTAMOL HYDROCHLORIDE (XOPENEX), TRAMADOL, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and AZELASTINE for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm was sore), CHILLS (chills), PYREXIA (temperature of 101.2 degrees Fahrenheit), HEADACHE (Headache) and MYALGIA (muscle ache). On 17-Apr-2021, the patient experienced VACCINATION SITE WARMTH (raised hot spot of 4 inches below the injection site) and FATIGUE (fatigued). The patient was treated with NAPROXEN SODIUM (ALEVE) on 17-Apr-2021 at an unspecified dose and frequency and PARACETAMOL (TYLENOL) on 17-Apr-2021 at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (raised hot spot of 4 inches below the injection site), PAIN IN EXTREMITY (arm was sore), CHILLS (chills), PYREXIA (temperature of 101.2 degrees Fahrenheit), HEADACHE (Headache), MYALGIA (muscle ache) and FATIGUE (fatigued) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, Body temperature: 101.2 degree fahrenheit (High) 101.2 Degree Fahrenheit. On 17-Apr-2021, Body temperature: 99.2 degree fahrenheit (High) 99.2 Degree Fahrenheit.         Other treatment Medication includes Ice pack  Action taken with mRNA-1273 in response to the event was not applicable.
Within 6 hours, fever started to increase to just under 103...confined to bed rest 9/4/21 and did not eat since Friday at noon...fever finally down to 99.8 on 9/5/21 which is 48 hours after injection. Feels like I have the flu...no cough or chest congestion...weak, lethargic, heart racing started 6 hours after but has subsided now.
a little less then 2 weeks after receiving the vaccine the patient states her arm began to  hurt from the shoulder to the elbow. The pain is strongest near her elbow.  She has not received any treatment and  has not spoke with a doctor about it yet.  this pain continues to this day (02/18/21) and has been unchanging.  patient was advised to contact her primary care doctor.
Arm soreness with swelling (size of lemon) and higher temperature under arm for 2 days
Itching and pain, injection site swelled up in a red welt, 6 inches long, 3 inches wide, hot to touch.
Both doses hurt like hell, the shot hurt; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain (received 1st shot on an unknown date and the patient had hurt like heck, the shot hurt, refer case US2022AMR025380).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR025380  Additional details were provided as follows: The patient self-reported this report. The age at vaccination was not reported. The patient got both Shingles shots and he/she mentioned that it hurted like heck, but rather had the shot hurt then to had shingles. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR025380:Same reporter.
Rash/cellulitis to left arm - started 10/26/15. Started on antibiotics for cellulitis and BENADRYL cream for itchiness.
RASH Narrative:  Pt admitted to psych unit, received both zoster vaccine and pssv23 vaccine; administered in the same arm (right arm) at the same time. Pt developed a rash the same day and day followed vaccines.
on 27JAN97 pt noted lt postauricular & lt cervical & postoccipital nodes (1/2 - 2 1/2cm size);on 30JAN97 pt devel a facial rash;by 30JAN97 had a red coalescent macular papular face rash & mac pap rash on trunk & arms;
Administration data indicates your location administered doses of the affected lot after the Sept. 30 expiration date but on or before Oct. 19. For doses administered between Oct. 1 and Oct. 19, with manufacturer data to support the stability and efficacy, revaccination is not indicated, and patient notification is not required. Any dose administered on or after Oct. 1 must be reported in VAERS
Site of injection has red mark; Site of injection is itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Site of injection has red mark) and VACCINATION SITE PRURITUS (Site of injection is itching) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Site of injection has red mark) and VACCINATION SITE PRURITUS (Site of injection is itching). At the time of the report, VACCINATION SITE ERYTHEMA (Site of injection has red mark) and VACCINATION SITE PRURITUS (Site of injection is itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Localized redness, warmth, swelling. No systemic Rxn. Complained of some burning right after injection but no Rxn until next day.
On Jan 8 I received the first Shingrix vaccine and on Jan 15 I completely lost my hearing in my left ear.  Right ear seems fine.  I wasn't doing anything significant at the time, just usual work on pc in the morning.  I went to an ENT (Dr) on Jan 17.  He confirmed the hearing loss and prescribed Prednisone which I took in decreasing doses for 1 week.  The follow-up hearing test found a minor improvement in hearing but still very impaired.
After 9-hour cross-continent flights, arrived at airport. Walked concourse toward baggage collection. Became dizzy. disoriented, unbalanced, nauseated, vomited. Called 911. Spent 3 days in Hospital, emergency room; 2 days in hospital room.
Information has been received from a female who was vaccinated SC with a 0.65 ml dose of Zostavax (Oka/Merck).  It was reported that the vaccine was stored above 5 degrees F for 25-27 minutes before reconstitution.  The patient experienced itching at injection site, "but it was not anything that I wouldn't expect".  A product quality complaint was not involved.  No further information is available.
the area of injection remained painful; Having swollen feet and swollen hands and it never subsided; This is a spontaneous report from a contactable consumer (patient). A 48-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 23Feb2021 10:20 (Batch/Lot Number: EN6203) at the age of 48-years-old, at single dose for covid-19 immunisation. Medical history included biopsy, and allergenic. Patient did not have vaccines prior vaccination within 4 weeks. Patient had no other medical history of illness, had no medical history. The patient's concomitant medications were not reported. The patient experienced having swollen feet and swollen hands and it never subsided and also the area of injection remained painful for about 6 to 8 weeks (medically significant) in Feb2021. Patient was currently taking prednisone for swollen feet which was triggered by, may be immune vaccine and viral and something like that, historically that's what, its caused for triggered by that, was patient's experience. The patient underwent lab tests and procedures which included blood count was normal on 08May2021, blood test was little lowers, potassium level in blood matter, chest scan to make sure that there was no blood clot and was unknown results, CT scan (computerised tomogram) was no fluid or excess on 17May2021, Antigen test to make sure that there was no blood clot and was unknown results, MRI (magnetic resonance imaging) was unknown results on 08May2021, urine analysis all of patient's blood count patient's hematology was unknown results on 08May2021. Therapeutic measures were taken as a result of events. Patient was given topical medication diphenhydramine hydrochloride (BENADRYL) and ointment for anti-infection ointment and was given recently, patient received prednisone, it was for auto immune reaction. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Very sore arm; Swelling of lymph nodes in armpit; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 23Apr2021 at 09:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 02Apr2021 at 08:45 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 11:00, the patient experienced very sore arm, swelling of lymph nodes in armpit and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events very sore arm, swelling of lymph nodes in armpit and fatigue were resolving at the time of the report.  No follow-up attempts are possible. No further information is expected.
Bell's Palsy; Other zoster-related conditions; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medication were not provided.   In 2015, the patient was vaccinated with a dose zoster vaccine live (ZOSTAVAX) (dosage regimen was not reported) for the long-term prevention of shingles (herpes zoster) and zoster-related conditions.   On an unspecified date, subsequent to the patient vaccination, the patient was treated by a physician for the following injuries resulting from the zoster vaccine live (ZOSTAVAX) vaccination: bell's palsy and other zoster-related conditions (ill-defined disorder). At the reporting time, the outcome of the events was unknown.   The reporter considered the events of bell's palsy and other zoster-related conditions (ill-defined disorder) to be related to zoster vaccine live (ZOSTAVAX).
flu type A; Initial information received on 28-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a patient.  This case involves an unknown age and unknown gender patient who had flu type A after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (form, strength, dose, frequency, site, route: unknown, with an unknown batch number and expiry date: unknown) for prophylactic vaccination (Immunisation)  On an unknown date the patient had non-serious event flu type A (influenza) (unknown latency)   No relevant lab tests were reported.  Reportedly "Had the shot...got the flu type A.."  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event  At time of reporting, the outcome was Unknown for the event
This vaccine altered me, nor did I know, that I had a venous insufficiency condition. It attacked the affected areas.
Day after the injection - body ache, chills, headache, pain in the left arm.  Symptoms were gone the following day. Two days later I started having severe headaches, pain in the neck and in the jaw, swelling of lymph nodes in neck, pain in lymph nodes under arms and in front and back of the neck, chills, body ache.  I've been having these symptoms for 7 days now with no  improvement.
4/10/17 Patient received PREVNAR 13 at office. 5/26/17 Seen in office for pain right arm. 6/2/17 Ultrasound negative.
Throwing up, nausea, severe headache, extreme fatigue, lethargy. I had a severe Covid 19 in March 2020.  There were no tests available in my area.  I had Bell's Palsy in October 2020 and have mostly recovered.  I have had daily headaches since March 2020.
Patient was in office on 4/17 for visit and was noted to need Menactra vaccine. Patient given vaccine 4/17 and per parent report on Friday the 18th she noted swelling to the left arm. Saturday the 19th of April parent took child to ER to be evaluated for swelling. Swelling approx 2 inches and redness from elbow to shoulder of left arm. Seemed to improve after Benadryl given. Then given Benadryl Q 4 hours X 24+ hours.  Was seen for follow up appointment on 4/22 and was recovered.
Very large rash on left thigh. Significant inflammation and significant swelling. Rash is hot to the touch. Unusual swelling and size of rash.
Patient received Pfizer 5-11 instead of Pfizer 12+ for second dose.
Muscle pain immediately after injection.   Woke at 1AM with fever and chills.  Fever was 101, took Advil.
OCD symptoms; This case was reported by a nurse via call center representative and described the occurrence of obsessive-compulsive disorder in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced obsessive-compulsive disorder. On an unknown date, the outcome of the obsessive-compulsive disorder was not recovered/not resolved.   It was unknown if the reporter considered the obsessive-compulsive disorder to be related to Bexsero.  Additional information was provided as follows: The age at vaccination was not reported. The patient developed OCD (obsessive-compulsive disorder) symptoms after receiving Bexsero. The symptoms had not improved with treatment. The reporter did not consent to follow up.
This spontaneous report was received from a healthcare worker regarding unspecified patients of unknown age and gender. Medical history and concurrent conditions of the patients were not reported. On an unknown date the patients were vaccinated with improperly stored VARIVAX (Merck) lot # L008270 expiry date 11-MAR-2017, L032391 expiry date 26-AUG-2017, lot 035127 expiry date 14-SEP-2017 (dose, route and site of administration not reported. This was following first temperature excursion of -7.4C for 8 hours. No adverse effects were reported. Temperature: 0.05C. Time frame: 9 hours 20 minutes. Based on these supportive parameters the improperly stored vaccines were administered after first excursion. No doses were administered after second excursion. There was previous temperature excursion (-7.4C for 8 hours). This is one of the several reports from the same reporter. Additional information has been requested.
Vertigo - short spells from head movement or bodily position change.  Happening multiple times in a day. Vestibular Physical Therapy: targeting weakness in right vestibular nerve.
Aches and fatigue began 12 hours after vaccination. Lasted approximately 24 hours afterwards.
Pfizer 10/12/21, 11/2/21. Positive on 2/5/22
Fever and weakness morning after vaccination (fever 99 to 100.4) persisted all day. Headache in evening. Profuse unusual bleeding from nostril before bed.
Received influenza 0.5mg IM left arm 10/21/2003.  On 10/26/2003 observed a non-itchy purple "rash" on left great toe left 2nd, 3rd toe, both legs extending to groin area, chest underneath both arms extending from wrist to elbows.  Notified MD.  No treatment at this time.  If not resolved in one week (11/03/2003) to see MD.  Has had flu vaccine annually with no ill effects. The follow up received on 11/11/03 states approximately five weeks ago, pt had tick bite on his right upper arm with a bull's eye rash which resolved without treatment. After receiving the flu vaccine on 10/21/03, his spouse noticed increased agitation while awake, but would readily fall asleep when sitting, loss of appetite and decreased interest in reading. He was seen by his dermatologist on 11/3/03 who diagnosed vasculitis and prescribed Cortisone cream 0.25% to the affected areas. On 11/4/03, pt was seen for a routine cardiology appointment and he was beginning to show signs of tremors and unsteady gait. He c/o chills and on 11/5/03 his T was 102 F. An appointment was made with his primary care physiican for 11/6/03. After being seen by his doctor, pt was admitted to hospital. Extensive blood work, neurology consult, leg lesion biopsy and medical consults have been done. He continues with unsteady gait and agitation.
Swelling @ site w/bruising (bruising noted immediately p/vax); tingling; swelling, pain, erythema @ site; indurated nodule w/faint well demarcated surrounding erythema; inc warmth; very tender; to ER; Rx: Keflex 500mg q 6hrs x 10 days ;
Patient was given wrong vaccine.  He was to be given Engerix B not Bexsero.
Pt. called on 10/10/10 c/o redness, swelling and warm to touch at injection site (L) arm. Office visit scheduled - Diagnosed with (L) arm cellulitis, treat with BACTRIM x 10 days, temp - 98 degrees.
27SEP phone call from mom, states pt devel rash on cheeks (red, raised rash) on 26APR92; On 27APR rash was generalized w/no itching, fever, cough, or other sx; encouraged to see MD:
A nurse reported that a child received a dose of DTaP  and subsequently developed a fever of 106F. No further info was received at the date of this report. This report is considered medically important. The reporter declined to provide additional information and declined to grant permission for follow up.
Shortness of breath, fever, chills, dyspnea, cough, nausea, loss of taste and chills. Hospitalized.
Information has been received from a 71 year old female with allergic reaction to FLAGYL who on 20-FEB-2009 was vaccinated with a dose of ZOSTAVAX (Oka/Merck).  Concomitant therapy included TEKTURNA, LOSARTAN POTASSIUM MSD, AMLODIPINE, NEXIUM, TRICOR, baby aspirin, and METOPROLOL.  In the night on 20-FEB-2009 the patient started to experience fever and chills and had been experiencing it since.  The fever only starts in the evening and she felt fine during the day.  The patient sought unspecified medical attention.  Additional information has been requested.
This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received PREVNAR 13, via an unspecified route of administration in 2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she received the shot 4 weeks ago and had an ongoing headache since unspecified date. Outcome of the event was not recovered.
went into seizure; felt a metallic taste; felt dizzy; nearly fainted; not able to walk; had chest tightness; did not feel like she could breathe; did not feel well; her face was flushed like she was on fire; A Spontaneous report was received from a physcian concerning a 63  Year old Female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Dysgeusia/Felt like metallic taste, Dizziness/Dizzy, Presyncope/ Near fainting, Gait Disturbance /Walking difficulty, Chest discomfort/ Chest tightness, Dyspnoea/ Breathing difficult, Malaise/ Feeling unwell, Seizure, Blood pressure abnormal, Blood sugar abnormal and Flushing.  The patient's medical history included Asthma.   No relevant concomitant medications were reported. No information on allergies were provided. The reported stated that the patient was physically and mentally healthy before vaccination.  On 9 Mar 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown)  via intramuscular route and unknown location for prophylaxis of COVID-19 infection.   had chest tightness and she is an asthma patient. She did not feel like she could breathe and did not feel well. She went back to the pharmacy and they did not want to give her EpiPen. She went into seizure because she already had seizure disorder. Her blood pressure went to 162/80 and her blood sugar went to 152 when she was on her way to the hospital and her face was flushed like she was on fire. She took Zofran during her 5 hours of hospitalization and got a CT scan. They diagnosed her with a post vaccination reaction but she still wants to get the second dose. Action taken with mRNA-1273 in response to the events was not reported.  The outcome for the event Dysgeusia, Dizziness, Presyncope, Walking difficulty, Chest discomforts, Dyspnoea, Malaise, Seizure, Blood pressure abnormal, Blood sugar abnormal and Flushing was considered unknown.; Sender's Comments: Based on the current available information which includes a strong temporal association between the use of the product and onset of the events, and excluding other etiologies but for history of asthma, causal relationship cannot be excluded.
I started having headaches, runny nose, sneezing, back hurt really bad, fatigue, diarrhea, cough, sore throat in wind pipe area, upset stomach, and I lost my smell and taste. I went to a clinic and they did a Covid test. It came back negative. They said it was a sinus infection but I had all the Covid symptoms. I took another Covid test and it came back positive. Its been over a month later and I still do not have taste or smell.
pt recv vax & devel urticaria, & swelling & exp itching following vax w/Hep B; No further details were provided;
Serious GI issues. Nausea, cramping, loss of appetite, weakness. Palpitations. Still on going.
Fever of 103.5, vomiting, diarrhea recovered within 48 hours
pt recv vax 14AUG95 & pt devel less than 50 lesions;
Pt admitted to the hospital the day after receiving second vaccination. Pt received vaccinations 2/10/2021 and 3/10/2021 at a facility, Moderna Lot # 025LZOA for both shots. Per pt husband she had started complaining of feeling tired and weak a few hours after receiving shot. She took a nap and when she awakened her legs were weak and she could not stand without assist and did end up falling a couple of times. When she was not feeling better in AM husband took her to the hospital.
Patient's arm was sore shortly after administration. Soreness went away but when patient woke up the following day she noticed redness at injection site which slowly spread to a larger area -- site also feels warm to touch. No other symptoms exhibited.